NeuroSearch has the ambitious goal of bringing at least two - three compounds into development each year, and is proud to report that this goal has been achieved on average the last three years. Today, NeuroSearch has a broad and diversified portfolio of development programmes within diseases with substantial market potential and unmet medical needs.
The following table shows the indications, which are targeted by each of the development programmes, as well as and underlying the mechanisms of action their respective developmental status:
